The pandemic has been characterized by poorly conceived policies and their inevitable reversals - with subsequent public outrage. However, these...
Read moreThe US Preventive Services Task Force recently changed its guidance on aspirin as a preventative medication, a major policy shift....
Read moreFirst principles thinking attempts to break down complex concepts into its fundamental parts. When we apply this thinking to healthcare,...
Read moreFall has yet to arrive, but already we hear warnings of a combined viral outbreak of influenza and COVID, despite...
Read moreOnce again, the CDC has revised its stance on masks, prompting a barrage of compliments and critiques. But the announcement...
Read moreThe alarm bells have rung, and the alarmists have spoken. COVID-19 is in resurgence. But to predict what this means...
Read moreOf all the issues plaguing healthcare, none is more pressing than our inability to see healthcare as a complex system....
Read moreThe WHO has introduced nomenclature redefining COVID-19 variants to prevent prejudices formed during the pandemic. But a close examination reveals...
Read moreAmerica is the land of optimism, with an undeniable taste for dystopian futures. One which pits technological advancements in medicine...
Read moreData drives healthcare, whether it is individual decisions or broader health policies. But data only tells us what we know,...
Read moreThe country has united in support of India. A unity nowhere to be found during our own COVID-19 crisis, revealing...
Read moreRecently the Johnson & Johnson vaccine was placed on hold. We studied data to compare the risk of blood clots...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy